Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Price

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
The Cochrane Database of Systematic Reviews|July 29, 2017
Oral versus intravenous fluoropyrimidines for colorectal cancerFiona Chionh, David Lau, Yvonne Yeung, et al.
Expert Review of Anticancer Therapy|May 1, 2023
Primary site and treatment impact in unresectable metastatic colorectal cancerTharani Krishnan, Fiona Wang, Chris Karapetis, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|May 11, 2006
A prospective randomised controlled trial comparing Merocel and Rapid Rhino nasal tampons in the treatment of epistaxisIoannis Moumoulidis, Mark R Draper, Hemi Patel, et al.
British Journal of Cancer|March 9, 2022
Immunotherapy use in oesophagogastric cancers-a review of the literatureAnnabel Smith, Amitesh Roy, Christos S Karapetis, et al.
Gastrointestinal Cancer Research : GCR|March 19, 2013
Hepatic encephalopathy associated with cancer or anticancer therapyKaspar J Willson, Louise M Nott, Vy T Broadbridge, et al.
BMC Cancer|January 28, 2023
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapyJulien Taieb, Timothy Price, Loïck Vidot, et al.
The Lancet. Gastroenterology & Hepatology|July 8, 2022
Dual αV-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 studyAndrew Dean, Sanjeev Gill, Mark McGregor, et al.
Asia-Pacific Journal of Clinical Oncology|April 30, 2020
Trifluridine/tipiracil: A practical guide to its use in the management of refractory metastatic colorectal cancer in AustraliaTimothy Price, Matthew Burge, Lorraine Chantrill, et al.
Asia-Pacific Journal of Clinical Oncology|November 7, 2017
Patient-reported experience of the impact and burden of neuroendocrine tumors: Oceania patient results from a large global surveyJohn Leyden, Nick Pavlakis, David Chan, et al.
The Cochrane Database of Systematic Reviews|November 19, 2020
Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinomaYoko Tomita, Max Moldovan, Rachael Chang Lee, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
The Cochrane Database of Systematic Reviews|July 29, 2017
Oral versus intravenous fluoropyrimidines for colorectal cancerFiona Chionh, David Lau, Yvonne Yeung, et al.
Expert Review of Anticancer Therapy|May 1, 2023
Primary site and treatment impact in unresectable metastatic colorectal cancerTharani Krishnan, Fiona Wang, Chris Karapetis, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|May 11, 2006
A prospective randomised controlled trial comparing Merocel and Rapid Rhino nasal tampons in the treatment of epistaxisIoannis Moumoulidis, Mark R Draper, Hemi Patel, et al.
British Journal of Cancer|March 9, 2022
Immunotherapy use in oesophagogastric cancers-a review of the literatureAnnabel Smith, Amitesh Roy, Christos S Karapetis, et al.
Gastrointestinal Cancer Research : GCR|March 19, 2013
Hepatic encephalopathy associated with cancer or anticancer therapyKaspar J Willson, Louise M Nott, Vy T Broadbridge, et al.
BMC Cancer|January 28, 2023
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapyJulien Taieb, Timothy Price, Loïck Vidot, et al.
The Lancet. Gastroenterology & Hepatology|July 8, 2022
Dual αV-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 studyAndrew Dean, Sanjeev Gill, Mark McGregor, et al.
Asia-Pacific Journal of Clinical Oncology|April 30, 2020
Trifluridine/tipiracil: A practical guide to its use in the management of refractory metastatic colorectal cancer in AustraliaTimothy Price, Matthew Burge, Lorraine Chantrill, et al.
Asia-Pacific Journal of Clinical Oncology|November 7, 2017
Patient-reported experience of the impact and burden of neuroendocrine tumors: Oceania patient results from a large global surveyJohn Leyden, Nick Pavlakis, David Chan, et al.
The Cochrane Database of Systematic Reviews|November 19, 2020
Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinomaYoko Tomita, Max Moldovan, Rachael Chang Lee, et al.
Pageof 13